How Investors May Respond To ACM Research (ACMR) Planetary Family Multi-Product Rebranding
ACM Research Inc. has rebranded its semiconductor equipment portfolio as the "ACM Planetary Family," grouping its tools into eight process-based series. This strategic reorganization aims to clarify its multi-product offerings and strengthen technology differentiation. While the rebranding itself doesn't alter near-term catalysts, it could help ACM Research sustain its growth targets, though investors must still weigh risks like China exposure and R&D commitments.
Vanguard realigns reporting; multiple entities to report ACMR holdings separately (ACMR)
Vanguard Group has filed an amended Schedule 13G/A, reporting 0 shares and 0% beneficial ownership of ACM Research Inc common stock. This change is due to an internal realignment on January 12, 2026, which will lead certain subsidiaries or business divisions to report their beneficial ownership separately. The filing relies on SEC Release No. 34-39538 for this disaggregated reporting, indicating no sale of shares but a change in reporting structure.
ACM Research (NASDAQ: ACMR) insider exercises 110,000 options and sells 110,000 shares
ACM Research director, officer, and major shareholder David H. Wang exercised 110,000 stock options at $1.00 per share and subsequently sold all 110,000 shares of Class A Common Stock. These sales, conducted on March 11-12, 2026, occurred at weighted average prices between $44 and $48, as part of a pre-arranged Rule 10b5-1 trading plan. After these transactions, Wang directly holds 802,708 shares, with additional indirect holdings through family members and trusts.
Options exercised as ACM Research (NASDAQ: ACMR) insider sells 98,551 shares
ACM Research (NASDAQ: ACMR) officer Mark McKechnie exercised stock options for 98,551 shares and subsequently sold all of them in open-market transactions. These sales, totaling approximately $4.49 million, were executed under a pre-arranged Rule 10b5-1 trading plan adopted in August 2025, indicating that the transactions were scheduled in advance and not discretionary. Following these transactions, McKechnie still holds 240,000 stock options and 60,900 shares of Class A Common Stock.
McKechnie Mark, CFO, sells ACMR stock worth $4.49 million
ACM Research, Inc.'s CFO, Mark McKechnie, sold 98,342 shares of Class A Common Stock for approximately $4.49 million on March 12, 2026, under a pre-arranged trading plan. Concurrently, he exercised options to acquire 98,551 shares. These transactions follow the company's fourth-quarter 2025 earnings which missed expectations, though an analyst firm maintained a "Buy" rating and raised its price target.
ACM Research (NASDAQ: ACMR) director trades 60K shares under 10b5-1 plan
ACM Research (NASDAQ: ACMR) director Tracy Liu performed an exercise-and-sell transaction involving 60,000 shares of Class A Common Stock. Liu exercised stock options at $1.00 per share and subsequently sold these shares in open-market transactions at prices ranging from $46.67 to $48.50 under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, Liu directly holds 110,772 shares of the company's Class A Common Stock.
ACM Research Director Wang David H Sells 110,000 Shares
ACM Research Director Wang David H sold 110,000 shares of Class A Common Stock for over $5.1 million in mid-March 2026, reducing his direct ownership to 802,708 shares. CFO Mark McKechnie also sold 98,551 shares for approximately $4.49 million, leaving him with 900 direct shares. Both transactions were executed under Rule 10b5-1 trading plans.
ACM Research (ACMR) Is Down 7.6% After ESOP Shelf Filing And Profitability Trade-Offs - Has The Bull Case Changed?
ACM Research recently filed a US$135.27 million shelf registration for its employee stock ownership plan, following 2025 results showing lower net income despite higher sales, indicating a trade-off between growth investment and current profitability. This filing, coupled with the dip in profitability and ongoing risks like China concentration, prompts a re-evaluation of the company's investment narrative, especially considering analyst forecasts for significant revenue and earnings growth by 2028 and a potential fair value upside. Investors are encouraged to look beyond the immediate stock price movement and delve into fundamental data and various perspectives to form their own conviction about ACMR's future.
ACM Research Officer Feng Lisa Sells 30,000 Shares
ACM Research's Chief Financial Officer, Feng Lisa, sold 30,000 shares of Class A Common Stock over two days in early March 2026. The sales, totaling $1,441,290, were executed under a Rule 10b5-1 trading plan. Following these transactions, Feng Lisa directly owns 50,001 shares.
ACM Research (NASDAQ: ACMR) director exercises options and sells 5,000 shares
ACM Research (NASDAQ: ACMR) director Haiping Dun exercised stock options for 5,000 Class A Common Stock shares at $5.60 each, then sold these shares in open-market transactions between $43–$44 per share. These sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted in August 2025. Following these transactions, Dun holds no direct Class A Common Stock but retains 55,000 stock options and significant indirect ownership through family trusts.
ACM Research Director Liu Tracy Sells 60,000 Shares
ACM Research Director, Liu Tracy, sold a total of 60,000 shares of Class A Common Stock in multiple transactions on March 10 and 11, 2026. The sales were executed under a Rule 10b5-1 trading plan at prices between $46.67 and $48.50, totaling $2,850,781. Following these transactions, Liu Tracy retains direct ownership of 110,772 shares in ACM Research.
ACM Research (ACMR) Is Down 7.6% After ESOP Shelf Filing And Profitability Trade-Offs - Has The Bull Case Changed?
ACM Research's stock dropped 7.6% after it filed a US$135.27 million shelf registration for its employee stock ownership plan, following full-year 2025 results that showed higher sales but lower net income. This situation highlights the company's trade-off between growth investment and current profitability, posing questions about the impact on its investment narrative, especially concerning potential dilution and risks associated with China exposure. Despite this, some analysts project significant revenue and earnings growth by 2028, suggesting a potential upside to its current stock price.
Officer at ACM Research (NASDAQ: ACMR) nets 30,000-share sale
Lisa Feng, an officer at ACM Research, exercised stock options for 30,000 shares of Class A Common Stock and subsequently sold all 30,000 shares in open-market transactions between March 5 and March 6, 2026. The sales were executed under a Rule 10b5-1 trading plan adopted on December 2, 2025, with weighted average prices ranging from $45.51 to $50.54. Following these transactions, Feng directly holds 50,001 shares of ACMR Class A Common Stock.
ACM Research (ACMR) Is Down 9.2% After Margin Squeeze Despite Higher 2025 Revenue - What's Changed
ACM Research (ACMR) saw its stock drop by 9.2% after reporting higher 2025 revenue but lower net income and EPS due to margin compression from rising R&D and expansion costs. The company's investment narrative focuses on its ability to translate semiconductor complexity into durable revenue while managing these cost pressures. While the company projects significant revenue and earnings growth by 2028, some analysts remain cautious, suggesting that if planned expansions and AI-driven demand underperform, a more conservative outlook could prevail.
Lawmakers Question Security of Intel's ACM Research Chip Tool Testing - News and Statistics
Bipartisan U.S. lawmakers have raised national security concerns regarding Intel's testing of chipmaking tools from ACM Research. The lawmakers worry that ACM Research, which has ties to sanctioned Chinese entities, could expose Intel's cutting-edge chipmaking processes to Chinese military companies. Intel maintains that ACM tools are not used in its production and that it fully complies with U.S. regulations.
ACM Research, Inc. Class A Trade Ideas — LSX:A2H62F
This article compiles several trading ideas for ACM Research, Inc. Class A (LSX:A2H62F, NASDAQ:ACMR), primarily focusing on long positions following a breakout on the weekly timeframe. Contributors discuss various strategies for setting price targets and managing risk, such as holding until previous lows are breached, using Fibonacci extensions, or selling when the price breaks below a short-term moving average. The analysis also includes observations on the stock's historical performance and the company's background.
ACM Research Expands Globally As Earnings Volatility Tests Growth Story
ACM Research has expanded its global footprint by delivering 300mm single wafer cleaning systems to Singapore, securing new advanced packaging orders, and completing a private share offering. Despite recent sales growth, the company experienced earnings volatility and margin pressure in Q4 2025 and for the full year. The capital injection and international expansion aim to diversify revenue and stabilize profitability amidst risks like exposure to China and high R&D spending.
ACM Research (ACMR) Margin Compression Challenges Bullish Growth Narratives After FY 2025 Results
ACM Research (ACMR) reported FY 2025 results with revenue of US$244.4 million and EPS of US$0.12 for Q4, and trailing twelve-month figures of US$901.3 million revenue and US$1.47 EPS. The company faces margin compression, with its net margin falling to 10.4% from 13.2% a year ago, challenging bullish growth narratives despite strong revenue forecasts. Valuation signals are mixed, with the stock trading below the US semiconductor industry average P/E but above its DCF fair value, indicating a complex outlook for investors.
ACM Research (Shanghai): Revenue and net profit both grew over 20% year-over-year, with robust R&D and strong cash returns
ACM Research (Shanghai) reported over 20% year-over-year growth in both revenue (RMB 6.79 billion) and net profit (RMB 1.40 billion), driven by strong domestic demand and increased R&D. The company maintained a 47.5% gross margin, invested 18.5% of revenue in R&D, and distributed 21.4% of earnings as cash dividends. This financial performance highlights robust growth and a commitment to R&D and shareholder returns.
ACM Research Inc (NASDAQ:ACMR) Reports Mixed Q4 2025 Results with Earnings Miss and Margin Pressure
ACM Research Inc (ACMR) reported mixed Q4 2025 financial results, with modest revenue growth of 9.4% year-over-year to $244.4 million, slightly missing estimates. However, the company delivered a significant earnings miss, posting non-GAAP diluted EPS of $0.25 against an estimated $0.408, primarily due to a sharp decline in gross margin from 49.6% to 40.9%. Despite the profitability pressures, ACMR achieved record full-year 2025 revenue and reiterated its robust 2026 revenue guidance, reflecting anticipated growth from new products and global expansion.
ACM Research Q4 Earnings Report: What Investors Need to Know
ACM Research (NASDAQ: ACMR) reported its Q4 earnings on February 26, 2026, missing estimated earnings by -26.47% with an EPS of $0.25 against an estimate of $0.34. Despite the miss, revenue grew by $20.96 million compared to the previous year. This earnings report follows a pattern where the company missed EPS in the prior quarter, which led to a 0.71% drop in share price the following day.
ACM Research Reports Fourth Quarter and Fiscal Year 2025 Results
ACM Research (NASDAQ: ACMR) announced strong financial results for the fourth quarter and full fiscal year 2025, with record annual revenue of $901 million, a 15% increase year-over-year. The company reported significant progress in product development and global expansion, including new cleaning tools shipped to Singapore and advanced packaging equipment orders from global customers, maintaining its 2026 revenue outlook of $1.08 billion to $1.175 billion.
ACM Research, Inc. $ACMR Shares Acquired by Rhumbline Advisers
Rhumbline Advisers significantly increased its stake in ACM Research (NASDAQ:ACMR) by 81.4% during the third quarter, now holding 147,794 shares valued at $5.78 million. Other institutional investors, including Principal Financial Group Inc., also boosted their positions, bringing total institutional ownership to 66.75%. Despite positive analyst ratings like Roth MKM's "buy" with a $40 price target, the company has seen some downgrades, and insiders sold approximately 250,000 shares worth $8.34 million in the last quarter, though insiders still retain 25% ownership.
Did Expectations for Lower EPS but Higher Sales Just Shift ACM Research's (ACMR) Investment Narrative?
ACM Research (ACMR) is drawing investor attention due to upcoming earnings expectations of lower EPS but higher year-over-year revenue, prompting questions about the company's balance between expansion and earnings quality. This shift highlights concerns about profitability defense amid heavy investment in capacity and R&D. The article suggests exploring alternative perspectives and building an individual investment narrative, noting that current forecasts indicate a 25% downside to its fair value.
ACM Research to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026
ACM Research, Inc. (NASDAQ: ACMR) announced it will release its fourth quarter and fiscal year 2025 financial results before the U.S. market open on Thursday, February 26, 2026. The company will also hold a conference call at 8:00 a.m. U.S. Eastern Time to discuss these results, with online registration available for participants.
Is ACM Research (ACMR) Pricing Reflect Semiconductor Equipment Hype Or Long Term Potential
This article analyzes ACM Research (ACMR) stock valuation using two methods. The Discounted Cash Flow (DCF) model suggests the stock is overvalued by 28.6% at $64.10 compared to an intrinsic value of $49.86 per share. However, when comparing its P/E ratio of 35.5x to its proprietary "Fair Ratio" of 40.3x, the stock appears undervalued, indicating that current pricing might reflect a mix of semiconductor equipment hype and long-term potential when considering different valuation perspectives.
ACM Research (ACMR) Valuation Check As China Quasi Monopoly And Cleaning Tools Draw Fresh Interest
Renewed attention on ACM Research (ACMR) is driven by its SAPS and TEBO cleaning tools and their role with leading memory makers, especially considering the impact of U.S. sanctions on competitors in China. Despite significant share price increases and momentum, the stock is currently trading above an average analyst price target, leading to questions about whether the surge has run its course. While a discounted cash flow model suggests the stock is overvalued at $62.48 compared to a fair value of $48.67, its current P/E ratio of 34.6x is below that of its peers (53.9x) and a fair ratio of 38.7x.
Why ACM Research’s China Quasi‑Monopoly in Chip Cleaning May Redefine Its Moat (ACMR)
ACM Research's proprietary SAPS and TEBO cleaning technologies have granted it a quasi-monopoly in China's chip cleaning market due to U.S. sanctions on rival suppliers. While this position supports solid revenue growth and a push into new areas, the company's heavy reliance on China and export controls pose risks, despite recent share price gains indicating potential overextension. Investors are encouraged to consider diverse fair value estimates and build their own investment narrative.
ACM Research sets preliminary price for Shanghai share sale at RMB 160 per share
ACM Research (NASDAQ: ACMR) has set a preliminary transfer price of RMB 160.00 (approximately $23.05) per share for a planned sale of 4,801,648 shares of its operating subsidiary, ACM Research (Shanghai), Inc., on the Shanghai Stock Exchange. The price was determined through an inquiry-based quotation process involving 38 institutional investors. This follows a recent Q3 2025 earnings report where the company exceeded revenue forecasts but missed EPS expectations.
ACM Research sets preliminary price for Shanghai share sale at RMB 160 per share
ACM Research's operating subsidiary, ACM Research (Shanghai), Inc., has set a preliminary transfer price of RMB 160.00 (approximately $23.05) per share for a planned sale of 4,801,648 shares on the Shanghai Stock Exchange. This price was determined through an inquiry-based quotation process involving 38 institutional investors. This development follows the company's Q3 2025 earnings report, where EPS fell short of expectations ($0.36 vs. $0.55 projected), but revenue exceeded forecasts ($269.2 million vs. $252.2 million projected).
ACM Research sets preliminary price for Shanghai share sale at RMB 160 per share
ACM Research (NASDAQ:ACMR) announced that its operating subsidiary, ACM Research (Shanghai), Inc., has set a preliminary transfer price of RMB 160.00 (approximately $23.05) per share for a planned sale of 4,801,648 shares on the Shanghai Stock Exchange. The price was determined through an inquiry-based quotation process. This sale represents about 1.34% of ACM Research’s ownership in the subsidiary and 1% of the subsidiary's outstanding shares.
Why ACM Research (ACMR) Is Up 16.6% After Raising 2025–2026 Revenue Guidance And What's Next
ACM Research (ACMR) saw its stock rise by 16.6% after updating its 2025 revenue outlook and providing new guidance for 2026, signaling clearer visibility into its future scale and demand. The company now expects 2025 revenue between US$885 million and US$900 million, and 2026 revenue between US$1.08 billion and US$1.18 billion. While the updated guidance offers concrete targets, investors are still advised to consider risks such as customer concentration, technology competitiveness, and geopolitical factors.
Did ACM Research’s New Revenue Targets and Oregon Expansion Plans Just Shift ACM Research's (ACMR) Investment Narrative?
ACM Research (ACMR) has updated its 2025 revenue outlook to US$885-US$900 million and provided 2026 guidance of US$1.08-US$1.18 billion, reflecting trade policies and market dynamics. The company also announced accelerated investments in Oregon and expansion of its semiconductor cleaning and furnace product lines to boost domestic chip production. This new guidance and investment strategy are seen as significantly shifting ACM Research's investment narrative, raising expectations for its future performance despite current share price volatility.
ACM Research Updates 2025 Revenue Outlook and Provides Initial Outlook for 2026 Revenue
ACM Research (NASDAQ: ACMR) has updated its full-year 2025 revenue outlook to $885 to $900 million and provided an initial 2026 revenue outlook of $1,080 to $1,175 million. The company expects higher revenue growth in 2026 due to healthy investments in production capacity, market share gains from newer products, and accelerating investments in Oregon to support domestic semiconductor production. ACM plans to release its fourth quarter and full year 2025 financial results in late February 2026.
What's Going On With ACM Research Stock Thursday?
ACM Research (NASDAQ: ACMR) stock increased on Thursday after the company updated its 2025 revenue outlook and provided a strong 2026 guidance that surpassed analyst expectations. The company anticipates stronger revenue growth in 2026, driven by production capacity investments, market share gains from new products, and contributions from its cleaning and furnace tools. ACM Research also plans to accelerate investments in Oregon to support domestic semiconductor manufacturing.
ACM Research Inc (ACMR) Q3 2025 Earnings Call Transcript
ACM Research Inc. reported strong Q3 2025 results with revenue up 32% year-over-year, driven by broad demand across its product portfolio. The company highlighted advancements in cleaning, electroplating, and panel-level packaging technologies, stressing innovation as a key driver for market share gains. ACM Research also updated its full-year 2025 revenue outlook and discussed strategic investments in R&D and production capacity.
Assessing ACM Research (ACMR) Valuation After Institutional Interest And Three Year Earnings Growth
ACM Research (ACMR) has seen significant institutional interest and robust growth with 44.5% 3-year sales growth and 41.6% EPS growth. Despite a strong share price performance, its P/E ratio of 29.6x suggests it might be undervalued compared to industry and peer averages, potentially offering a buying opportunity. However, a Discounted Cash Flow (DCF) model indicates the stock is currently overvalued, presenting a mixed signal for investors to consider.
ACM Research Inc (ACMR) Q3 2025 Earnings Call Transcript
ACM Research Inc. (ACMR) reported strong Q3 2025 earnings, with revenue growing 32% year-over-year to a new record of $269 million, driven by demand across its product portfolio. The company highlighted advancements in cleaning, electroplating, and advanced packaging technologies, and reiterated its commitment to innovation for next-generation chipmaking. ACMR narrowed its full-year 2025 revenue outlook to between $875 million and $925 million, representing a 15% year-over-year growth at the midpoint.
ACM Research Updates 2025 Revenue Forecast to $885-$900 Million; Projects 2026 Revenue of $1,080-$1,175 Million
ACM Research has updated its 2025 revenue forecast to $885-$900 million, a slight adjustment from its previous range. The company projects significant growth for 2026, with an expected revenue of $1,080-$1,175 million, driven by investments in production capacity and market share expansion. These projections are influenced by international trade policies, customer spending, supply chain factors, and new product introductions.
ACM Research Updates 2025 Revenue Outlook and Provides Initial Outlook for 2026 Revenue
ACM Research (NASDAQ: ACMR) has updated its 2025 revenue outlook to $885 to $900 million and provided an initial 2026 revenue outlook of $1,080 to $1,175 million. The company anticipates higher revenue growth in 2026 due to investments in production capacity, market share gains from new products, and accelerating investments in Oregon to support domestic semiconductor production. ACM plans to release its Q4 and full-year 2025 financial results in late February 2026.
Campbell & CO Investment Adviser LLC Takes Position in ACM Research, Inc. $ACMR
Campbell & CO Investment Adviser LLC recently acquired a new stake of 51,822 shares in ACM Research (NASDAQ:ACMR) during the third quarter, valued at approximately $2.03 million. Other institutional investors have also adjusted their positions in the company, which currently has 66.75% institutional ownership. Despite missing EPS estimates, ACM Research reported
ACM Research, Inc. (ACMR) increases despite market slip: Here's what you need to know
ACM Research, Inc. (ACMR) stock saw a gain of 0.81% in the last trading session, outperforming the S&P 500's decline of 1.29%. This increase was despite the company missing earnings and revenue estimates in its last quarterly report. Investors are anticipating ACMR's next earnings report, due on March 6, 2024, to see if the company can demonstrate renewed growth.
ACM Research (ACMR) Faces Softer Earnings Expectations Is Its Semiconductor Tool Margins Story Intact?
ACM Research (ACMR) is facing softer earnings expectations but higher revenue forecasts leading up to its January 22, 2026 earnings release. Despite a recent stock surge and analyst optimism, investors need to consider the company's significant exposure to the Chinese semiconductor market and the potential impact of trade policies. Simply Wall St's fair value estimate of $41.64 suggests a 22% downside from its current price, highlighting differing opinions among analysts and the importance of individual research.
Why Investors Shouldn't Be Surprised By ACM Research, Inc.'s (NASDAQ:ACMR) 30% Share Price Surge
ACM Research, Inc. (NASDAQ:ACMR) has experienced a significant 30% share price surge over the last month, contributing to a 209% increase over the past year. Despite its high price-to-earnings (P/E) ratio of 26.4x compared to the broader U.S. market, the article suggests this is justified by the company's strong earnings growth, which has grown 26% in the last year and is projected to continue at 16% annually for the next three years, outpacing the market's 12% forecast. Investors seem confident in ACM Research's future prospects, hence the higher P/E multiple.
ACM Research (ACMR) Valuation Check After Semiconductor Rally And Upcoming 2025 2026 Outlook Updates
ACM Research (ACMR) has gained significant attention following a strong rally in semiconductor stocks, with its shares seeing substantial returns over the past year. While a narrative valuation suggests the stock is currently 10.3% overvalued at $45.00 against a fair value of $40.81, its P/E ratio of 24.9x is considerably lower than the US semiconductor industry average of 38.7x. The company's investments in manufacturing and R&D capacity aim to support future growth, though potential risks include export controls and prolonged spending squeezing margins.
ACMR stock flirts with a fresh 52-week high as ACM Research nears Jan. 22 outlook update
ACM Research Inc. (ACMR) stock rose to $45.34, nearing its 52-week high of $46.09, as investors anticipate its preliminary 2025 revenue and initial 2026 outlook update on January 22. The company, a chip-equipment maker, will also participate in the Needham Growth Conference. This update is crucial for setting expectations for semiconductor tools demand, especially as the broader semiconductor sector shows strength.
Does ACM Research’s (ACMR) New Multiyear Revenue Outlook Clarify Its Long-Term Demand Visibility?
ACM Research (ACMR) is set to release its preliminary fiscal 2025 revenue range and initial 2026 outlook on January 22, along with participation in the Needham Growth Conference. This upcoming guidance and investor meetings are drawing market attention to customer spending plans and their impact on demand for ACM’s semiconductor manufacturing equipment. The article discusses how this new outlook will influence ACM Research's investment narrative, particularly given its significant exposure to China and the potential for U.S.-China technology restrictions.
Should You Be Adding ACM Research (NASDAQ:ACMR) To Your Watchlist Today?
ACM Research (NASDAQ:ACMR) has demonstrated strong earnings per share growth of 35% annually over the last three years and 21% revenue growth to US$880m over the past year. Insiders hold a significant 12% stake in the company, valued at US$316m, aligning their interests with shareholders. Additionally, the CEO's compensation of US$499k in 2024 is considerably lower than the average for similar-sized companies, suggesting good governance and a shareholder-friendly remuneration culture.
ACM Research to Release Full-Year 2025 Preliminary Revenue Range and Initial 2026 Revenue Outlook on January 22, 2026
ACM Research, Inc. (NASDAQ: ACMR) announced it will release its preliminary revenue range for fiscal year 2025 and an initial 2026 revenue outlook before the U.S. market opens on January 22, 2026. The company will also virtually participate in the 28th Annual Needham Growth Conference and hold one-on-one meetings on January 15, 2026. ACM Research is a leading supplier of wafer and panel processing solutions for semiconductor and advanced packaging applications.
ACM Research, Inc. to Announce Preliminary 2025 Revenue Range and 2026 Outlook on January 22, 2026
ACM Research, Inc. (NASDAQ: ACMR) will announce its preliminary 2025 revenue range and provide an initial 2026 revenue outlook on January 22, 2026, before the U.S. market opens. The company will also participate virtually in the 28th Annual Needham Growth Conference and hold one-on-one meetings on January 15, 2026. This announcement includes details on insider trading activity, hedge fund movements, and analyst ratings for ACMR.
